| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.3 | 7e-09 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | -0.23 | 7e-09 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | -0.24 | 1e-08 |
| mRNA | austocystin d | CTRPv2 | pan-cancer | AAC | 0.23 | 4e-08 |
| mRNA | piperlongumine:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.21 | 2e-07 |
| mRNA | GSK429286A | GDSC1000 | pan-cancer | AAC | -0.2 | 2e-07 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | -0.21 | 2e-07 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.26 | 5e-07 |
| mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | -0.2 | 5e-07 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | -0.18 | 6e-07 |